Carregant...
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and...
Guardat en:
| Publicat a: | Mult Scler Relat Disord |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier B.V.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7335234/ https://ncbi.nlm.nih.gov/pubmed/32650121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102372 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|